A Phase III, Randomized, Open-Label, Multiple-Dose, Parallel-Group Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity of Recombinant Human FSH of Cadila Healthcare Limited, India as compared to Gonal-F TM Administered Subcutaneously in Female Patients Undergoing Assisted Reproductive Technology.
Phase of Trial: Phase III
Latest Information Update: 30 Dec 2017
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Sponsors Cadila Healthcare
- 15 Dec 2017 Status changed from recruiting to completed.
- 06 Feb 2017 Status changed from not yet recruiting to recruiting.
- 16 Nov 2016 New trial record